N. YALÇIN And K. Allegaert, "COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed," European Journal of Clinical Pharmacology , vol.78, no.10, pp.1697-1701, 2022
YALÇIN, N. And Allegaert, K. 2022. COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed. European Journal of Clinical Pharmacology , vol.78, no.10 , 1697-1701.
YALÇIN, N., & Allegaert, K., (2022). COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed. European Journal of Clinical Pharmacology , vol.78, no.10, 1697-1701.
YALÇIN, NADİR, And Karel Allegaert. "COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed," European Journal of Clinical Pharmacology , vol.78, no.10, 1697-1701, 2022
YALÇIN, NADİR And Allegaert, Karel. "COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed." European Journal of Clinical Pharmacology , vol.78, no.10, pp.1697-1701, 2022
YALÇIN, N. And Allegaert, K. (2022) . "COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed." European Journal of Clinical Pharmacology , vol.78, no.10, pp.1697-1701.
@article{article, author={NADİR YALÇIN And author={Karel Allegaert}, title={COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed}, journal={European Journal of Clinical Pharmacology}, year=2022, pages={1697-1701} }